Browse > Article
http://dx.doi.org/10.5483/BMBRep.2019.52.7.137

mTOR signalling pathway - A root cause for idiopathic autism?  

Ganesan, Harsha (Human Molecular Cytogenetics and Stem Cell Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University)
Balasubramanian, Venkatesh (Human Molecular Cytogenetics and Stem Cell Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University)
Iyer, Mahalaxmi (Department of Zoology, Avinashilingam Institute for Home Science and Higher Education for Women)
Venugopal, Anila (Human Molecular Cytogenetics and Stem Cell Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University)
Subramaniam, Mohana Devi (Department of Genetics and Molecular Biology, Vision Research Foundation)
Cho, Ssang-Goo (Department of Stem Cell and Regenerative Biotechnology, Konkuk University)
Vellingiri, Balachandar (Human Molecular Cytogenetics and Stem Cell Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University)
Publication Information
BMB Reports / v.52, no.7, 2019 , pp. 424-433 More about this Journal
Abstract
Autism spectrum disorder (ASD) is a complex neurodevelopmental monogenic disorder with a strong genetic influence. Idiopathic autism could be defined as a type of autism that does not have a specific causative agent. Among signalling cascades, mTOR signalling pathway plays a pivotal role not only in cell cycle, but also in protein synthesis and regulation of brain homeostasis in ASD patients. The present review highlights, underlying mechanism of mTOR and its role in altered signalling cascades as a triggering factor in the onset of idiopathic autism. Further, this review discusses how distorted mTOR signalling pathway stimulates truncated translation in neuronal cells and leads to downregulation of protein synthesis at dendritic spines of the brain. This review concludes by suggesting downstream regulators such as p70S6K, eIF4B, eIF4E of mTOR signalling pathway as promising therapeutic targets for idiopathic autistic individuals.
Keywords
Autism spectrum disorder (ASD); Downstream regulators; Idiopathic autism; mTOR signalling pathway; Therapeutic Target;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Viana SD, Reis F and Alves R (2018) Therapeutic Use of mTOR Inhibitors in Renal Diseases: Advances, Drawbacks, and Challenges. Oxid Med Cell Longev 2018, 3693625   DOI
2 Lawrence J and Nho R (2018) The role of the mammalian target of rapamycin (mTOR) in pulmonary fibrosis. Inter J Mol Sci 19, 778   DOI
3 Chau GC, Im DU, Kang TM et al (2017) mTOR controls ChREBP transcriptional activity and pancreatic ${\beta}$ cell survival under diabetic stress. J Cell Biol 216, 2091-2105   DOI
4 Striano P, Zara F (2012) Genetics: mutations in mTOR pathway linked to megalencephaly syndromes. Nat Rev Neurol 8 (10), 542
5 Mirzaa GM, Campbell CD, Solovieff N et al (2016) Association of MTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism. JAMA Neurol 73, 836-845   DOI
6 Lee JH, Huynh M, Silhavy J et al (2012) De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet 44, 941   DOI
7 Panner A, James CD, Berger MS, Pieper RO (2005) mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells. Mol Cell Biol 25, 8809-8823   DOI
8 Lim JS, Kim W, Kang HC et al (2015) Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Nat Med 21 (4), 395   DOI
9 Ryskalin L, Lazzeri G, Flaibani M et al (2017) mTOR-dependent cell proliferation in the brain. Biomed Res Int 2017, 14
10 Harker CM, Stone WL (2014) Comparison of the Diagnostic Criteria for Autism Spectrum Disorder Across DSM-5, DSM-IV-TR, 2 and the Individuals with Disabilities Act (IDEA) 3 Definition of Autism, 1-6
11 King BH, Navot N, Bernier R, Webb SJ (2014) Update on diagnostic classification in autism. Curr Opin Psychiatry 27, 105   DOI
12 Howes OD, Rogdaki M, Findon JL et al (2018) Autism spectrum disorder: Consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology. J Psychopharmacol 32, 3-29
13 Venugopal A, Chandran M, Eruppakotte N, Kizhakkillach S, Breezevilla SC and Vellingiri B (2018) Monogenic diseases in India. Mutat Res 776, 23-31   DOI
14 Nicolini C, Ahn Y, Michalski B, Rho JM and Fahnestock M (2015) Decreased mTOR signaling pathway in human idiopathic autism and in rats exposed to valproic acid. Acta Neuropathol Commun 3, 3   DOI
15 Sandin S, Lichtenstein P, Kuja-Halkola R, Larsson H, Hultman CM and Reichenberg A (2014) The familial risk of autism. JAMA 311, 1770-1777   DOI
16 Volk HE, Lurmann F, Penfold B, Hertz-Picciotto I and McConnell R (2013) Traffic-related air pollution, particulate matter, and autism. JAMA Psychiatry 70, 71-77   DOI
17 Costa-Mattioli M and Monteggia LM (2013) mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat Neurosci 16, 1537-1543   DOI
18 Berko ER, Suzuki M, Beren F et al (2014) Mosaic epigenetic dysregulation of ectodermal cells in autism spectrum disorder. PLoS Genet 10, e1004402   DOI
19 St-Hilaire S, Ezike VO, Stryhn H and Thomas MA (2012) An ecological study on childhood autism. Int J of Health Geogr 11, 44   DOI
20 Tordjman S, Davlantis KS, Georgieff N et al (2015) Autism as a disorder of biological and behavioral rhythms: toward new therapeutic perspectives. Front Pediatr 3, 1   DOI
21 Winden KD, Ebrahimi-Fakhari Dand Sahin M (2018) Abnormal mTOR activation in autism. Annu Rev of Neuro 41, 1-23   DOI
22 Lee HK, Kwon B, Lemere CA et al (2017) mTORC2 (Rictor) in Alzheimer's disease and reversal of amyloid-${\beta}$ expression-induced insulin resistance and toxicity in rat primary cortical neurons. J Alz Dis 56, 1015-1036   DOI
23 Dan HC, Ebbs A, Pasparakis M, Van Dyke T, Basseres DS and Baldwin AS (2014) Akt-dependent activation of mTORC1 Involves phosphorylation of mTOR by IKKalpha. J Bio Chem 289, 25227-25240   DOI
24 Takei N and Nawa H (2014) mTOR signaling and its roles in normal and abnormal brain development. Front Mol Neuro 7, 28   DOI
25 Muranen T, Selfors LM, Worster DT et al (2012) Inhibition of PI3K/mTOR leads to adaptive resistance in matrixattached cancer cells. Cancer cell 21, 227-239   DOI
26 Sawicka K and Zukin RS (2012) Dysregulation of mTOR signaling in neuropsychiatric disorders: therapeutic implications. Neuropsychopharma 37, 305   DOI
27 Sharma A, Hoeffer CA, Takayasu Y et al (2010) Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci 30, 694-702   DOI
28 Sun J, Liu Y, Moreno S, Baudry M, Bi X (2015) Imbalanced mechanistic target of rapamycin C1 and C2 activity in the cerebellum of Angelman syndrome mice impairs motor function. J Neurosci 35, 4706-4718   DOI
29 Piven J, Elison JT and Zylka MJ (2017) Toward a conceptual framework for early brain and behavior development in autism. Mol psych 22, 1385   DOI
30 Lipton JO and Sahin M (2014) The neurology of mTOR. Neuron 84, 275-291   DOI
31 Nicolini C and Fahnestock M (2018) The valproic acid-induced rodent model of autism. Exper Neuro 299, 217-227   DOI
32 Kelleher III RJ and Bear MF (2008) The autistic neuron: troubled translation? Cell 135, 401-406   DOI
33 Liu X, Campanac E, Cheung HH et al (2017) Idiopathic autism: cellular and molecular phenotypes in pluripotent stem cell-derived neurons. Mol Neurobiol 54, 4507-4523   DOI
34 Meyza KZ and Blanchard DC (2017) The BTBR mouse model of idiopathic autism-Current view on mechanisms. Neurosci Biobehav Rev 76, 99-110   DOI
35 Onore C, Yang H, Van de Water J and Ashwood P (2017) Dynamic Akt/mTOR signaling in children with autism spectrum disorder. Front Pediat 5, 43
36 De Rosa BA, El Hokayem J, Artimovich E et al (2018) Convergent Pathways in Idiopathic Autism Revealed by Time Course Transcriptomic Analysis of Patient-Derived Neurons. Scienti Rep 8, 8423   DOI
37 Showkat M, Beigh MA and Andrabi KI (2014) mTOR signaling in protein translation regulation: implications in cancer genesis and therapeutic interventions. Mol Biol Int 2014, 14
38 Dowling RJ, Topisirovic I, Alain T et al (2010) mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science 328, 1172-1176   DOI
39 Kanne SM, Gerber AJ, Quirmbach LM, Sparrow SS, Cicchetti DV and Saulnier CA (2011) The role of adaptive behavior in autism spectrum disorders: Implications for functional outcome. J Autism Dev Disord 41, 1007-1018   DOI
40 Josse L, Xie J, Proud CG and Smales CM (2016) mTORC1 signalling and eIF4E/4E-BP1 translation initiation factor stoichiometry influence recombinant protein productivity from GS-CHOK1 cells. Biochem J 473, 4651-4664   DOI
41 Jernigan CS, Goswami DB, Austin MC et al (2011) The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 35, 1774-1779   DOI
42 Zhao XF and Gartenhaus RB (2009) Phospho-p70S6K and cdc2/cdk1 as therapeutic targets for diffuse large B-cell lymphoma. Expert Opin Ther Targets 13, 1085-1093   DOI
43 Xiao Z, Casey KA, Jameson SC, Curtsinger JM and Mescher MF (2009) Programming for CD8 T cell memory development requires IL-12 or type I IFN. J Immunol 182, 2786-2794   DOI
44 Shott RH, Appanah C, Grenier C, Tremblay G, Roucou X and Schang LM (2014) Development of kinomic analyses to identify dysregulated signaling pathways in cells expressing cytoplasmic PrP. Virol J 11, 175   DOI
45 Cao R, Robinson B, Xu H (2013) Translational control of entrainment and synchrony of the suprachiasmatic circadian clock by mTOR/4E-BP1 signaling. Neuron 79, 712-724   DOI
46 Gkogkas CG, Khoutorsky A, Ran I et al (2013) Autismrelated deficits via dysregulated eIF4E-dependent translational control. Nature 493, 371   DOI
47 Dennis MD, Kimball SR and Jefferson LS (2013) Mechanistic target of rapamycin complex 1 (mTORC1)-mediated phosphorylation is governed by competition between substrates for interaction with raptor. J Bio Chem 288, 10-19   DOI
48 Bahrami BF, Ataie-Kachoie P, Pourgholami MH, and Morris DL (2014) p70 Ribosomal protein S6 kinase (Rps6kb1): an update. J Clin Pathol 12, 1019-1025
49 Bahrami F, Pourgholami MH, Mekkawy AH, Rufener L and Morris DL (2014) Monepantel induces autophagy in human ovarian cancer cells through disruption of the mTOR/p70S6K signalling pathway. Am J Can Res 4, 558-571
50 Biever A, Valjent E and Puighermanal E (2015) Ribosomal protein S6 phosphorylation in the nervous system: from regulation to function. Front Mol Neuro 8, 75
51 Kwon CH, Luikart BW, Powell CM et al (2006) Pten regulates neuronal arborization and social interaction in mice. Neuron 50, 377-388   DOI
52 Gatto CL and Broadie K (2010) Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models. Front Synaptic Neurosci 2, 4   DOI
53 Subramanian M, Timmerman CK, Schwartz JL, Pham DL and Meffert MK (2015) Characterizing autism spectrum disorders by key biochemical pathways. Front Neurosci 9, 313   DOI
54 Hutsler JJ, Zhang H (2010) Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res 1309, 83-94   DOI
55 Horgusluoglu E, Nudelman K, Nho K, and Saykin AJ (2017) Adult neurogenesis and neurodegenerative diseases: A systems biology perspective. Am J Med Genet B Neuropsychiatr Genet 174, 93-112   DOI
56 Betizeau M and Dehay C (2016) From stem cells to comparative corticogenesis: a bridge too far? Stem cell Investing 3, 39   DOI
57 Osborne LR (2010) Caveat mTOR: aberrant signaling disrupts corticogenesis. J Clin Invest 120, 1392-1395   DOI
58 Zatkova M, Bakos J, Hodosy J and Ostatnikova D (2016) Synapse alterations in autism: Review of animal model findings. Biomed Pap Med Fac Uni Palacky Olomouc Czech Repub 160, 201-210   DOI
59 Ishii K, Kubo KI and Nakajima K (2016) Reelin and neuropsychiatric disorders. Frontiers Cell Neurosci 10, 229
60 Oblak AL, Gibbs TT and Blatt GJ (2010) Decreased GABAB receptors in the cingulate cortex and fusiform gyrus in autism. J Neurochem 114, 1414-1423   DOI
61 Notwell JH, Heavner WE, Darbandi SF et al (2016) TBR1 regulates autism risk genes in the developing neocortex. Genome Res 26, 1013-1022   DOI
62 Hanashima C and Toma K (2015) Switching modes in corticogenesis: mechanisms of neuronal subtype transitions and integration in the cerebral cortex. Front Neurosci 9, 274   DOI
63 Thomanetz V, Angliker N, Cloetta D et al (2013) Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology. J Cell Biol 201, 293-308   DOI
64 Ogawa S, Kwon CH, Zhou J, Koovakkattu D, Parada LF and Sinton CM (2007) A seizure-prone phenotype is associated with altered free-running rhythm in Pten mutant mice. Brain Res 1168, 112-123   DOI
65 Lafourcade CA, Lin TV, Feliciano DM, Zhang L, Hsieh LS and Bordey A (2013) Rheb activation in subventricular zone progenitors leads to heterotopia, ectopic neuronal differentiation, and rapamycin-sensitive olfactory micronodules and dendrite hypertrophy of newborn neurons. J Neurosci 33, 2419-2431   DOI
66 Tavazoie SF, Alvarez VA, Ridenour DA, Kwiatkowski DJ and Sabatini BL (2005) Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci 8, 1727   DOI
67 Weston MC, Chen H and Swann JW (2014) Loss of mTOR repressors Tsc1 or Pten has divergent effects on excitatory and inhibitory synaptic transmission in single hippocampal neuron cultures. Front Mol Neurosci 7, 1   DOI
68 Choi YJ, Di Nardo A, Kramvis I et al (2008) Tuberous sclerosis complex proteins control axon formation. Genes Dev 22, 2485-2495   DOI
69 Williams E and Casanova M (2011) Above genetics: lessons from cerebral development in autism. Transl Neurosci 2, 106-120
70 Chen J, Yu S, Fu Y and Li X (2014) Synaptic proteins and receptors defects in autism spectrum disorders. Front Cell Neurosci 8, 276
71 Lahiri DK, Sokol DK, Erickson C, Ray B, Ho CY and Maloney B (2013) Autism as early neurodevelopmental disorder: evidence for an $sAPP{\alpha}$-mediated anabolic pathway. Front Cell Neuro 7, 94   DOI
72 Wisniewska MB (2013) Physiological role of ${\beta}$-catenin/TCF signaling in neurons of the adult brain. Neurochem Res 38, 1144-1155   DOI
73 Feliciano DM, Su T, Lopez J, Platel JC and Bordey A (2011) Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice. J Clin Invest 121, 1596-1607   DOI
74 Won H, Mah W and Kim E (2013) Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses. Front Molecu Neurosci 6, 19   DOI
75 Lin TV, Hsieh L, Kimura T, Malone TJ and Bordey A (2016) Normalizing translation through 4E-BP prevents mTOR-driven cortical mislamination and ameliorates aberrant neuron integration. Proc Natl Acad Sci U S A 113, 11330-11335   DOI
76 Oron O and Elliott E (2017) Delineating the Common Biological Pathways Perturbed by ASD's Genetic Etiology: Lessons from Network-Based Studies. Int J Molecu Sci 18, 828   DOI
77 Ichtchenko K, Hata Y, Nguyen T et al (1995) Neuroligin 1: a splice site-specific ligand for ${\beta}$-neurexins. Cell 81, 435-443   DOI
78 Noelanders R and Vleminckx K (2017) How Wnt signaling builds the brain: bridging development and disease. Neuroscientist 23, 314-329   DOI
79 Al-Zahrani A (2013) Prevalence and clinical characteristics of autism spectrum disorders in school-age children in Taif-KSA. Int J Med Sci Public Health 2, 578-582   DOI
80 Wen Y, Alshikho MJ and Herbert MR (2016) Pathway network analyses for autism reveal multisystem involvement, major overlaps with other diseases and convergence upon MAPK and calcium signaling. PLoS One 11, e0153329   DOI
81 Conciatori F, Ciuffreda L, Bazzichetto C et al (2018) mTOR cross-talk in cancer and potential for combination therapy. Cancers 10, 23   DOI
82 O'Loghlen A, Perez-Morgado MI, Salinas M and Martin ME (2006) N-acetyl-cysteine abolishes hydrogen peroxideinduced modification of eukaryotic initiation factor 4F activity via distinct signalling pathways. Cell Signal 18, 21-31   DOI
83 Laplante M and Sabatini DM (2009) mTOR signaling at a glance. J Cell Sci 122, 3589-3594   DOI
84 Murugan AK, Alzahrani A and Xing M (2013) Mutations in critical domains confer the human mTOR gene strong tumorigenicity. J Bio Chem 288, 6511-6521   DOI
85 Audet-Walsh E, Dufour CR, Yee T et al (2017) Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer. Genes Dev 31, 1228-1242   DOI
86 Xu J, Pham CG, Albanese SK et al (2016) Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin. J Clin Invest 126, 3526-3540   DOI
87 Davis NM, Sokolosky M, Stadelman K et al (2014) Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention. Oncotarget 5, 4603   DOI
88 Samidurai A, Kukreja RC and Das A (2018) Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases. Oxid Med Cell Longev 2018, 23
89 Jung NH, Janzarik WG, Delvendahl I et al (2013) Impaired induction of long-term potentiation-like plasticity in patients with high-functioning autism and Asperger syndrome. Dev Med Child Neurol 55, 83-89   DOI
90 Gilbert J and Man HY (2017) Fundamental elements in autism: from neurogenesis and neurite growth to synaptic plasticity. Front Cell Neurosci 11, 359   DOI
91 Jiang YH, Wang Y, Xiu X, Choy KW, Pursley AN and Cheung SW (2014) Genetic diagnosis of autism spectrum disorders: the opportunity and challenge in the genomics era. Crit Rev Clin Lab Sci 51, 249-262   DOI
92 Mattila ML, Kielinen M, Linna SL et al (2011) Autism spectrum disorders according to DSM-IV-TR and comparison with DSM-5 draft criteria: an epidemiological study. J Am Acad Child Adolesc Psychiatry 50, 583-592   DOI